INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• A New Era Of ADC Development Demands A New Kind Of Partner

  Explore how to navigate the evolution of antibody-drug conjugates by mastering AI-driven selection, dose optimization, and new regulatory strategies for earlier-line clinical success.

• The Power Of A Collaboration Platform

  Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.

• Elevating The Site Voice

  A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

• Scout Belongs In Your eClinical Solution Suite

  Traditional eClinical platforms manage data, but not participation. Learn how to fill the gap with travel, payments, and support that keep patients engaged, sites focused, and trials moving forward.

• AI in Pharma: Benefits, Risks, And The Road Ahead

  10/23/2024

  How could leveraging AI technologies, including machine learning (ML) and generative AI (GenAI), enable your company to streamline processes from drug discovery to post-launch?

• Reframing Clinical Vendor Selection

  7/2/2025

  Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.

• Clinical Trials Are The Global Biopharma Industry's Biggest Headache

  12/23/2025

  Explore how technology-driven, patient-centered innovation is transforming clinical trials to reduce risk, improve efficiency, and deliver smarter development outcomes.

• Five Predictions For Clinical Research In 2025

  2/19/2025

  In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.

• Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?

  3/25/2026

  This clip examines why shifting study timelines expose weaknesses in rigid RTSM systems and highlights how flexible technology helps trials stay on track when plans inevitably change.